EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

Nurse's Role Clinical Trial

Official title:

EVALUATION OF THE EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05625672
• Other study ID #: 2022-38
• Status: Completed
• Phase: N/A
• Start date: April 25, 2022
• Est. completion date: July 8, 2022

Study information

• Verified date: November 2022
• Source: Ankara Yildirim Beyazit University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.

Description:

125 nurses from the clinic and intensive care units, who received the most intensive blood transfusion from two different hospitals, were included in the study as the intervention and control groups. The control group was not trained. Only the pretest was administered one week after the posttest. After the pre-test was applied to the nurses in the intervention group, five modules of training, which lasted four hours, were given using interactive methods. Five modules of training were prepared by the researcher. These five modules are the 1st module of training; definition of hemovigilance, its aims, the development of hemovigilance in the world and in Turkey, and legal legislation, Module 2; Donor selection, Blood donation Process, Phlebotomy and Donor reactions, Module 3; blood, blood transfusion, its purpose, properties of blood and blood components, Blood transfusion process, Module 4; acute and delayed transfusion reactions and management, Module 5; It consists of the national hemovigilance system, the organization of the hemovigilance system at the hospital level, Traceability, Trace-back from the Patient to the Donor, and Look-back from the Donor to the Patient. the training was over, the final test was administered. One month later, this test was repeated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 125
• Est. completion date: July 8, 2022
• Est. primary completion date: May 26, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

She/He voluntarily agrees to participate in the research, Working as a nurse in the clinic and intensive care unit where blood transfusions are the most, Working for at least 6 months, Exclusion Criteria: Nurses working in the emergency and operating rooms, in clinics where blood transfusion is not performed the most, Being a new nurse, On maternity leave and maternity leave, Having an external assignment, Nurses working in the polyclinic,

Related Conditions & MeSH terms

• Hypersensitivity
• Nurse's Role
• Training Group, Sensitivity

Intervention

Other:
• Training
Hemovigilance module training

Locations

Country	Name	City	State
Turkey	Ankara Yildirim Beyazit University	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Ankara Yildirim Beyazit University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hemovigilance Information Form	It consists of fifteen questions about hemovigilance and hemovigilance system and definitions.	5 hours or 1 month
Primary	Information Form on Blood Transfusion Complications	This section consists of nine questions including transfusion complications.	5 hours or 1 month
Primary	Information Form on Blood Transfusion Applications	This section consists of sixteen questions including donor selection, questions about blood components, blood group and safe blood transfusion.	5 hours or 1 month